GH1 and neurofibromatosis type 1: Although the mechanism underlying excess GH in NF1 is still unknown, a loss of somatostatinergic inhibition from OPTs with dysregulation of GH secretion is suspected, particularly in tumors close to the hypothalamic and pituitary regions.